project id: TCGA-PRAD; case submitter id: TCGA-G9-6336; selected normal wgs: true; source center: 22; state: released; age at index: 57; days to birth: -20851; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1950; age at diagnosis: 20851; ajcc clinical m: M0; ajcc clinical t: T2c; ajcc pathologic n: N0; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2068.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 3; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 4; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 34.0; days to sample procurement: 0; intermediate dimension: 0.3; longest dimension: 0.4; oct embedded: No; shortest dimension: 0.2; portion submitter id: TCGA-G9-6336-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 20.0; percent neutrophil infiltration: 2.0; percent normal cells: 15.0; percent stromal cells: 20.0; percent tumor cells: 65.0; percent tumor nuclei: 70.0;